Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Cancer Research|January 1, 1981
Long-term association of N-(phosphonacetyl)-L-aspartate with boneB Ardalan, T W Kensler, H N Jayaram, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1991
A phase II study of weekly 24-hour infusion with high-dose fluorouracil with leucovorin in colorectal carcinomaB Ardalan, L Chua, E M Tian, et al.
Medical and Pediatric Oncology|January 1, 1983
Continuous five-day infusion of PALA and 5FU: a pilot phase II trialC A Presant, B Ardalan, P Multhauf, et al.
American Journal of Clinical Oncology|August 1, 1991
Phase II trial of mitoxantrone in head and neck carcinomaK S Sridhar, A M Hussein, P Benedetto, et al.
American Journal of Clinical Oncology|October 1, 1994
A phase II trial of recombinant leukocyte interferon plus doxorubicin in patients with hepatocellular carcinomaL G Feun, N Savaraj, S Hung, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Prochlorperazine as a doxorubicin-efflux blocker: phase I clinical and pharmacokinetics studiesK S Sridhar, A Krishan, T S Samy, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group studyC G Leichman, T R Fleming, F M Muggia, et al.
Cancer Research|March 1, 1981
Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acidT W Kensler, G Mutter, J G Hankerson, et al.
Pageof 5